Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CJS Securities Upgrades Vicor to Market Outperform

CJS Securities analyst Jonathan Tanwanteng upgrades Vicor (NASDAQ:VICR) from Market Perform to Market Outperform.

byBenzinga Newsdesk

October 26, 2022

1 minute read

CJS Securities analyst Jonathan Tanwanteng upgrades Vicor (NASDAQ:VICR) from Market Perform to Market Outperform.

Analyst Ratings

4 Analysts Have This to Say About Realty Income

By Benzinga Insights

Today, 5:03 AM

Over the past 3 months, 4 analysts have published their opinion on Realty Income (NYSE:O) stock. These analysts…

Senior US Official Says All Members In Nuclear Deal Other Than Iran Have Made Clear Vienna Talks Need To Resume As Soon As Possible

By Benzinga Newsdesk

Today, 5:03 AM

-Reuters

SPY

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

By Benzinga Newsdesk

Today, 5:03 AM

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $30 to $22.

OCUL

Novanta To Acquire Schneider Electric Motion USA For $115M Cash

By Anusuya Lahiri

Today, 5:03 AM

Novanta Inc (NASDAQ:NOVT) inked an agreement to acquire Schneider Electric Motion USA (SEM, IMS, or Intelligent Motion Systems) for $115 million…

NOVT

CJS Securities Upgrades Vicor to Market Outperform

Related Posts

4 Analysts Have This to Say About Realty Income

Senior US Official Says All Members In Nuclear Deal Other Than Iran Have Made Clear Vienna Talks Need To Resume As Soon As Possible

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

Novanta To Acquire Schneider Electric Motion USA For $115M Cash